Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07507903 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device

Study acronym: OBPM_PANDA2026
StatusRecruiting
PhaseNot applicable
SponsorAktiia SA
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Apr 20, 2026 to Apr 14, 2026 · Site details revisedv4 Show 2 more changesShow less
    • Start date changed from estimate of Apr 20, 2026 to Apr 14, 2026
    • Site details revised
  2. Study title shortened, about 1 wordv3 See this version in full on ClinicalTrials.gov ↗
  3. Study title shortened, about 12 wordsv2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aktiia SA
9 trials monitored
See all monitored trials
Hypertension
1,795 trials monitored
See 85 trials at risk
This study, with N = 85 participants minimum over 3 visits spread over 7 days, has been designed to assess the accuracy and precision of the Blood Pressure and pulse rate values as generated by Aktiia.product-G1-US for up to 7 days after initialization in a cohort of subjects representative of the US population.
Trial Details
NCT Number NCT07507903
Lead Sponsor Aktiia SA
Conditions Hypertension
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov